Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics

YM Chiu, DY Chen - Expert Review of Clinical Immunology, 2020 - Taylor & Francis
Introduction: Despite the therapeutic effectiveness of biologics targeting immune cells or
cytokines in patients with inflammatory arthritis, which reflects their pathogenic roles, an …
被引用次数：70 相关文章

[引用][C] Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics

YM Chiu, DY Chen - Expert Review of Clinical Immunology, 2020 - cir.nii.ac.jp
Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus
biologics | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics

YM Chiu, DY Chen - EXPERT REVIEW OF CLINICAL …, 2020 - ir.csmu.edu.tw
Introduction: Despite the therapeutic effectiveness of biologics targeting immune cells or
cytokines in patients with inflammatory arthritis, which reflects their pathogenic roles, an …

Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics.

YM Chiu, DY Chen - Expert Review of Clinical Immunology, 2020 - europepmc.org
Introduction: Despite the therapeutic effectiveness of biologics targeting immune cells or
cytokines in patients with inflammatory arthritis, which reflects their pathogenic roles, an …

Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics

YM Chiu, DY Chen - Expert review of clinical immunology, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction: Despite the therapeutic effectiveness of biologics targeting immune cells or
cytokines in patients with inflammatory arthritis, which reflects their pathogenic roles, an …